Effect of oral ibuprofen on patent ductus arteriosus in premature newborns
- PMID: 23960586
- PMCID: PMC3727378
- DOI: 10.1016/j.jsha.2010.03.002
Effect of oral ibuprofen on patent ductus arteriosus in premature newborns
Abstract
Background aim of the study: Patent ductus arteriosus (PDA), a common finding among premature infants, is conventionally treated by intravenous indomethacin. Intravenous ibuprofen was recently shown to be as effective and to have fewer adverse reactions in preterm infants. If equally effective, then oral ibuprofen for PDA closure would have several important advantages over the intravenous route. This study was designed to determine whether oral ibuprofen treatment is efficacious and safe in closure of a PDA in premature infants.
Patients and methods: Thirty-three premature group I (study group) were treated with ibuprofen 10 mg/kg administered through a feeding tube. Thirty-three premature group II (control group) receive placebo the two imaging procedures were again performed 24 h after each ibuprofen dose. When the PDA was still hemodynamically significant, as demonstrated by echocardiography, and there was no evidence of deterioration in brain ultrasonography, a second dose of ibuprofen 5 mg/kg (placebo for control) was administered. A third equivalent dose was given after another 24 h if necessary. Cranial ultrasound was repeated 1 week after the last ibuprofen dose and again before discharge from the ward. Hematochemical analysis was preformed daily in the unit during the first days of life.
Results: In the study group the rate of PDA closure was 93.9% (31 of 33 cases) while in the control group the rate of PDA closure was 30.3% (10 of 33 cases) with significant difference in between. There was no reopening of the ductus after closure had been achieved. No infant required surgical ligation of the ductus in study group while in the control group 24.2% (8 of 33 cases) were required surgical ligation (Table 2). Twenty-one newborns were treated with 1 dose of ibuprofen, 9 were treated with 2 doses, and the remaining 3 were treated with 3 doses.
Conclusion: Oral ibuprofen is an effective and safe alternative to intravenous ibuprofen for PDA closure in premature infants.
Keywords: Echocardiography; Oral ibuprofen; PDA closure; Patent ductus arteriosus; Premature newborn.
Similar articles
-
Closure of patent ductus arteriosus with oral ibuprofen suspension in premature newborns: a pilot study.Pediatrics. 2003 Nov;112(5):e354. doi: 10.1542/peds.112.5.e354. Pediatrics. 2003. PMID: 14595076
-
Oral ibuprofen in early curative closure of patent ductus arteriosus in very premature infants.Am J Perinatol. 2007 Jun;24(6):339-45. doi: 10.1055/s-2007-981853. Epub 2007 Jun 12. Am J Perinatol. 2007. PMID: 17564958
-
Ibuprofen for the treatment of patent ductus arteriosus in preterm or low birth weight (or both) infants.Cochrane Database Syst Rev. 2020 Feb 11;2(2):CD003481. doi: 10.1002/14651858.CD003481.pub8. Cochrane Database Syst Rev. 2020. PMID: 32045960 Free PMC article.
-
A comparison of oral ibuprofen and intravenous indomethacin for closure of patent ductus arteriosus in preterm infants.J Med Assoc Thai. 2003 Aug;86 Suppl 3:S563-9. J Med Assoc Thai. 2003. PMID: 14700149 Clinical Trial.
-
Comparison of Various Pharmacologic Agents in the Management of Hemodynamically Significant Patent Ductus Arteriosus in Preterm: A Network Meta-Analysis and Risk-Benefit Analysis.Biomed Hub. 2022 Oct 24;7(3):125-145. doi: 10.1159/000526318. eCollection 2022 Sep-Dec. Biomed Hub. 2022. PMID: 36465804 Free PMC article. Review.
Cited by
-
Does crossover treatment of control subjects invalidate results of randomized trials of patent ductus arteriosus treatment?J Perinatol. 2020 Dec;40(12):1863-1870. doi: 10.1038/s41372-020-00848-z. Epub 2020 Oct 6. J Perinatol. 2020. PMID: 33024260 Review.
-
Early treatment versus expectant management of hemodynamically significant patent ductus arteriosus for preterm infants.Cochrane Database Syst Rev. 2025 Jun 23;6(6):CD013278. doi: 10.1002/14651858.CD013278.pub3. Cochrane Database Syst Rev. 2025. PMID: 40548426 Review.
-
A Global Perspective on PDA Management in the Extremely Premature: Shifting Trend Toward Transcatheter Closure.J Soc Cardiovasc Angiogr Interv. 2023 May 19;2(4):100968. doi: 10.1016/j.jscai.2023.100968. eCollection 2023 Jul-Aug. J Soc Cardiovasc Angiogr Interv. 2023. PMID: 39131651 Free PMC article. Review.
-
Efficacy and Costs of Three Pharmacotherapies for Patent Ductus Arteriosus Closure in Premature Infants.Paediatr Drugs. 2022 Mar;24(2):93-102. doi: 10.1007/s40272-022-00495-1. Epub 2022 Mar 1. Paediatr Drugs. 2022. PMID: 35229248
-
Association of Placebo, Indomethacin, Ibuprofen, and Acetaminophen With Closure of Hemodynamically Significant Patent Ductus Arteriosus in Preterm Infants: A Systematic Review and Meta-analysis.JAMA. 2018 Mar 27;319(12):1221-1238. doi: 10.1001/jama.2018.1896. JAMA. 2018. PMID: 29584842 Free PMC article.
References
-
- Chemtob S., Beharry K., Rex J., Varma D.R., Aranda J.V. Prostanoids determine the range of cerebral blood flow autoregulation of newborn piglets. Stroke. 2000;21:777–784. - PubMed
-
- Chemtob S., Laudignon N., Beharry K., Rex J., Wolfe L., Varma D.R., Aranda J.V. Effects of prostaglandins and indomethacin on cerebral blood flow and oxygen consumption of conscious newborn piglets. Dev. Pharmacol. Ther. 2004;14:1–14. - PubMed
-
- Chemtob S., Beharry K., Barna T., Varma D.R., Aranda J.V. Differences in the effect in the newborn piglet of various nonsteroidal antiinflammatory drugs on cerebral blood flow but not on cerebrovascular prostaglandins. Pediatr. Res. 2007;30:106–111. - PubMed
-
- Cherif A., Jabnoun S., Khrouf N. Oral ibuprofen in early curative closure of patent ductus arteriosus in very premature infants. Am. J. Perinatol. 2007;24(6):339–345. - PubMed
-
- Coceani F., White E., Bodach E., Olley P.M. Age-dependent changes in the response of the lamb ductus arteriosus to oxygen and ibuprofen. Can. J. Physiol. Pharmacol. 1998;57:825–831. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials